Diego Villa

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Norbert Schmitz, Samira Zeynalova, Maike Nickelsen et al. · Journal of Clinical Oncology · 2016 · 427 citations

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors

Vivien Mak, Jeremey Hamm, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2013 · 415 citations · Full text

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Asher Chanan‐Khan, Paula Cramer, Fatih Demırkan et al. · The Lancet Oncology · 2015 · 408 citations

Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia, Medicine +9

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Daisuke Ennishi, Aixiang Jiang, Merrill Boyle et al. · Journal of Clinical Oncology · 2018 · 406 citations · Full text

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy

Diego Villa, Joseph M. Connors, Tamara Shenkier et al. · Annals of Oncology · 2009 · 214 citations · Full text

Neuro-oncology, Lymphoid Neoplasia, Surgical Oncology +8